Education
About Us
Working with TipRanks
Follow Us
Astrana Health (ASTH)
NASDAQ:ASTH
ASTH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$23.12 - $63.20
Previous CloseN/A
Volume92.25K
Average Volume (3M)372.40K
Market Cap
$1.55B
Enterprise Value$1.49B
Total Cash (Recent Filing)$288.45M
Total Debt (Recent Filing)$46.54M
Price to Earnings (P/E)35.5
Beta1.23
Next Earnings
May 13, 2025EPS Estimate
0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.90
Shares Outstanding50,119,700
10 Day Avg. Volume394,809
30 Day Avg. Volume372,396
Financial Highlights & Ratios
PEG Ratio0.80
Price to Book (P/B)N/A
Price to Sales (P/S)0.85
Price to Cash Flow (P/CF)-39.70
P/FCF Ratio9.50
Enterprise Value/Market Cap0.96
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.73
Enterprise Value/Ebitda11.80
Forecast
1Y Price Target
$49.86Price Target Upside61.94% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
---
Astrana Health News
PremiumCompany Announcements
Astrana Health Highlights Strategic Acquisition Plans
PremiumCompany Announcements
Astrana Health Updates Corporate Presentation for Conferences
PremiumCompany Announcements
Astrana Health’s Earnings Call: Growth Amid Challenges---
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactAdding Prospect Health deepens Astrana Health's competitive edge in Southern California as a scaled entry point to a competitive Orange County.
Market PositionAstrana Health is viewed as a leading operator in the advanced primary care space, consistently delivering strong execution.
Strategic InvestmentsUnanticipated costs related to novel AI investments are expected to enhance margins over time.
Bears Say
Financial PerformanceExpected EBITDA for 2025 is below investor expectations, ranging from $170m to $190m.
Integration RiskThe price target for Astrana Health Inc. has been lowered to $40 to reflect elevated execution and integration risk.
Medicaid RiskMedicaid risk is perceived as misunderstood, with potential financial impacts that could affect earnings.
---
Ownership Overview
48.12% Insiders
16.90% Mutual Funds
7.54% Other Institutional Investors
4.93% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ASTH FAQ
What was Astrana Health’s price range in the past 12 months?
Astrana Health lowest stock price was $23.12 and its highest was $63.20 in the past 12 months.
What is Astrana Health’s market cap?
Astrana Health’s market cap is $1.55B.
When is Astrana Health’s upcoming earnings report date?
Astrana Health’s upcoming earnings report date is May 13, 2025 which is in 48 days.
How were Astrana Health’s earnings last quarter?
Astrana Health released its earnings results on Feb 27, 2025. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of $0.099 by -$0.249.
Is Astrana Health overvalued?
According to Wall Street analysts Astrana Health’s price is currently Undervalued.
Does Astrana Health pay dividends?
Astrana Health does not currently pay dividends.
What is Astrana Health’s EPS estimate?
Astrana Health’s EPS estimate is 0.31.
How many shares outstanding does Astrana Health have?
Astrana Health has 50,119,700 shares outstanding.
What happened to Astrana Health’s price movement after its last earnings report?
Astrana Health reported an EPS of -$0.15 in its last earnings report, missing expectations of $0.099. Following the earnings report the stock price went down -26.817%.
Which hedge fund is a major shareholder of Astrana Health?
Currently, no hedge funds are holding shares in ASTH
---
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$49.86 (61.94% Upside)
$49.86 (61.94% Upside)
Hedge Fund Trend
Increased
By 45.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 8.7%
Last 30 Days ▼ 8.7%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.61%
12-Months-Change
Fundamentals
Return on Equity
6.50%
Trailing 12-Months
Asset Growth
43.96%
Trailing 12-Months
Company Description
Astrana Health
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
---
ASTH Company Deck
---
ASTH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Astrana Health showed strong revenue growth and strategic expansion through acquisitions, but faced challenges due to strategic investment costs, Medicaid utilization headwinds, and high integration costs relating to acquisitions.Read More>---
ASTH Stock 12 Month Forecast
Average Price Target
$49.86
▲(61.94% Upside)
Technical Analysis
Best Analysts Covering ASTH
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
+11.85%
reiterated a buy rating 6 months ago
Copying David Larsen's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +11.85% per trade.
---